Used as an intermediate in pharmaceutical synthesis, particularly in the development of central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of a substituted pyrrolidine ring, which is common in compounds with neurological activity. Commonly employed in research settings for designing new drug candidates, especially those targeting receptors or enzymes involved in neurological disorders. Also utilized in the preparation of analogs for structure-activity relationship studies.